From October 1, 2022 to November 30, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 1,133,035 shares, representing 0.19% for CNY 94.57 million under the buyback announced on March 30, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.18 CNY | +0.04% | -4.75% | -8.73% |
29/04 | Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
15/04 | Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% | MT |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.73% | 4.03B | |
+16.57% | 1.87B | |
-13.87% | 621M | |
-15.90% | 447M | |
-81.65% | 216M | |
-15.31% | 109M | |
-9.42% | 55.64M |
- Stock Market
- Equities
- 688065 Stock
- News Cathay Biotech Inc.
- Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on March 30, 2022.